Previous study has been implied that the activated NLRP3 can lead to the Caspase-1 mediated release of proinflammatory factors such as interleukin-18 (IL-18) and IL-1β to trigger the inflammatory outburst in COPD mice [12]. Here, NLRP3 is linked to chronic obstructive pulmonary disease.